Hunters in cameroon help scientists track monkey virus spillover
NCT ID NCT03225794
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at how foamy viruses, common in monkeys and apes, might spread to people in rural Cameroon. Researchers will test blood samples from villagers, especially hunters, for signs of the virus. The goal is to understand the early steps of how animal viruses emerge in humans, which could help prevent future outbreaks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could reveal how viruses jump from animals to humans, helping predict and prevent future outbreaks.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct health benefits, and findings may be limited to this specific region and virus.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,600 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2010
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The survey has been and will be carried out in villages in southern Cameroon and the target population will change during the four phases of the study as follows: 1. Initially, all adults encountered (Phase 1). 2. In the second phase, people who have been in physical contact with monkeys (bites, scratches, wounds, etc.) mainly during hunting and the cleaning of bushmeat 3. Finally, after screening: focus on infected individuals and inclusion of their immediate family (mainly spouses and children) to study potential intrafamilial transmission (Phase 3). 4. For infected individuals, an annual clinical, biological and immunological examination, for 3 years (Phase 4). An uninfected person matched for age, sex, ethnic group, and locality will be recruited as a control for each case.
- Ages
-
5 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Living in a rural zone of Cameroon * Being \> 5 yrs old * Having received study information and having provided written consent for self and children, if applicable (for all phases) Exclusion Criteria: * Having refused to provide consent * Being less than 5 years old
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Simian foamy virus infection (disorder) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre Pasteur du CAmeroun
RECRUITINGYaoundé, Cameroon